Trending...
- Abusive Russian to face Pro Wrestling Legend!
- Can Massage Therapy Be an Effective Treatment for Long Haul COVID?
- Southern California Real Estate Agent Promotes Homes To MORE Buyers For MORE Money
QView's AI-QVCAD, combined with GEHC's ABUS breast ultrasound system, potentially accelerates the acceptance of 3D breast ultrasound as supplemental screening for women with dense breast tissue.
LOS ALTOS, Calif. - iSportsWire -- QView, Inc., a medical technology leader providing artificial intelligence systems for breast cancer detection, and GEHC have signed a distribution agreement where QView Medical's AI-QVCAD software system will be added to GEHC's portfolio of breast imaging AI solutions for the detection and diagnosis of breast cancer.
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on iSports Wire
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on iSports Wire
--
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on iSports Wire
- 24th Annual Super Bowl Soulful Celebration Returns On Feb. 8 With Patti LaBelle, Israel Houghton & The Players Choir, Honoring NFL QB Jalen Hurts
- Orbex to Exhibit as Diamond Sponsor at the Fintech & Crypto Summit Bahrain, 2023
- Photography Book Makes Black History Month Fun
- Historic Groundbreaking Documentary About Women Marathoners Released for Black History Month
- 3DMyRental Launches Professional 3D Floor Plan Services for Airbnb Hosts: A Game-Changing Solution for Property Rentals
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on iSports Wire
- Best Online End-Of-Season Clearance Sale at Sunber Hair: $56 For A Lace Wig
- UNice Hair Partners With Awin Affiliate Marketing Network To Accelerate Business Growth
- My Lineage Proudly Supports Knights of Heroes
- The Town Of Sun Village California Makes History As The First Black Tribal Township In North America
- Flawless Torres ft. Diamonique x Sean Kingston Releases "Lets Go" on 1/27/23!
--
- Boyd, et al, NEJM Jan 2007
- Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women with Dense Breast Tissue (Yulei Jiang). Read More: https://www.ajronline.org/doi/10.2214/AJR.18.19516
- Performance and Reading Time of Automated Breast US with or without Computer-aided Detection. Read More: https://pubs.rsna.org/doi/10.1148/radiol.2019181816
Source: Qview Medical, Inc.
0 Comments
Latest on iSports Wire
- New Cincinnati Bengals Playoff Win Has Fans Buying Sweatshirts, Hats, TShirts And Other Items
- "Boca's Best Body" competition Presented by The Berman Team
- ATM Processing Provider DNS Certifies Just.Cash Bitcoin Program
- Hyderabad Approves Richardson | Danner Master Plan
- Seasoned Risk Stalwart Brian Hughes Joins Scienaptic As An Investor And Advisor
- Tobu Railway Begins Selling Mobile Version of NIKKO PASS Via Klook
- Engine Prelubrication Systems Saves Money on both large and small engines
- Bjj News: 10 ways to get really good at Brazilian Jiu Jitsu fast
- Orbital Media's 1st Annual Chili Cook-Off
- December 2022 Financial Market Review
- Mondo announces new track and field scholarships in Lauren McCluskey's name
- Veterans For Trump endorsements of Joe Kent for congress, Kelli Ward for RNC and Salleigh Grubbs for GOP
- Black Female-Owned Sneaker Brand, TRONUS, Signs 13 NIL Athletes with Fraction Partnership
- TenCate Advanced Armor presents the Cratus™ Wave, a thinner Level III ballistic plate
- 360 Protective Solutions on the Importance of Executive Protection For Executives and VIPs
- Kidly Combines Tech with Timely Themes on Children's Reading Platform App
- Swapifly Wins Fintech Award for "Best Artificial Intelligence Classified Platform" in 2022
- Terry Hendricks Honored by DFW Real Producers as Top 1% Realtor
- "Breaking Three Hours-Trailblazing African American Women Marathoners" Available on Prime Video
- Jeron Pro-Alert™ Area of Rescue System is First to Reach UL2525 Listing